Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy

Transgelin-2 is a 22 kDa actin-binding protein that has been proposed to act as an oncogenic factor, capable of contributing to tumorigenesis in a wide range of human malignancies. However, little is known whe...

Source: Journal of Hematology and Oncology - March 17, 2021 Category: Hematology Authors: Hye-Ran Kim, Jeong-Su Park, Jin-Hwa Park, Fatima Yasmin, Chang-Hyun Kim, Se Kyu Oh, Ik-Joo Chung and Chang-Duk Jun Tags: Research Source Type: research